Search

everythinglearnresearchcommunity

for

Search:↓

Most patients experienced hirsutism again after stopping hormone treatment, indicating long-term treatment is needed to maintain results.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

Gonadal hormones may influence sex differences in play fighting in animals, but their effect on human spatial behavior is unclear and needs more research.

Chromium, inositol, and omega-3 can help manage PCOS symptoms.

Precocious puberty in girls is linked to cosmetics, pollution, light exposure, early sexual information, diet, and hereditary factors.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

Male rats grow hair faster than females, and certain hormones can slow or slightly increase hair growth, but not significantly beyond natural rates.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Hormonal imbalances, including high prolactin and thyroid issues, contribute to hair growth problems in women.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Most women referred for excess male hormone symptoms had polycystic ovary syndrome (PCOS), with other conditions being less common.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

Creating evidence-based guidelines for gender incongruence is difficult due to the personalized nature of transgender medicine.

Evaluate and manage androgen excess in women with a systematic approach, considering both physical and psychological impacts.

Measuring certain hormones can help predict metabolic risk in women with PCOS.

Male rats have more somatostatin neurons than females due to testosterone converting to estrogen during early development.

High levels of male hormones are very common in women with PCOS and affect their metabolism differently depending on their weight.

Normal levels for certain hormones in Chinese women of reproductive age were identified.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

A woman's hair loss was linked to a rare hormone-secreting ovarian tumor, treated with surgery and hair loss medication.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

Finasteride reduces alcohol withdrawal severity in male mice but increases it in female mice.

Sex neurosteroids cause different effects on hippocampal synaptic plasticity in males and females.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.